ArticleBMC public health2026
Spatiotemporal analysis of hospitalizations, mortality and access to intravenous thrombolysis for ischemic stroke in Southern Brazil.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlobally, stroke is a leading cause of mortality and disability, affecting approximately 15 million people annually. This study aimed to analyze hospitalizations, deaths, and thrombolysis for ischemic stroke in Southern Brazil, evaluate access within the 4.5-hour window at Neurological Reference Centers (NRCs), and explored potential coverage expansions.
methodsAn ecological study was conducted using hospitalization data, intravenous thrombolysis administration, and ischemic stroke related deaths among individuals aged 40–79 years treated in the Brazilian Unified Health System and residing in the Southern region between 2015 and 2024. Space Cube Time analyses, the Enhanced Two-Step Floating Catchment Area method, and spatial coverage simulations for potential new centers using the Maximal Covering Location Problem model were applied.
resultsThe Space-Time Cube analysis revealed no significant temporal trends in hospitalization and mortality rates due to ischemic stroke (Mann–Kendall test, p = 1.000), while a statistically significant increasing trend was observed in the use of thrombolytic therapy (trend = 3.0411; p = 0.0024), despite only 5% of hospitalized patients receiving the treatment. Furthermore, greater distance and travel time to NRCs were associated with higher mortality rates: municipalities located within two hours of an NRC showed a lower mean mortality rate (14.88 per 100,000 inhabitants) compared with those beyond this range (17.35 per 100,000 inhabitants), representing a difference of 2.47 deaths per 100,000 inhabitants (p < 0.005). Given this disparity, the simulation of adding 10 new NRCs, in addition to the 49 existing ones, estimated the prevention of 21.45 deaths per year, totaling approximately 214 deaths avoided over a decade.
conclusionThe combined findings of low intravenous thrombolysis utilization, limited access to NRCs, and higher mortality rates in inland municipalities underscore the need to expand specialized stroke care. Moreover, the simulation results indicate that broadening the coverage of NRCs could inform health policy planning aimed at reducing inequities in stroke care and lowering mortality and morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.